KMTS · Kestra Medical Technologies, Ltd.

Track KMTS — free

$22.85 -0.72 (-3.05%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$1.34B

58.60M

Up next

Next earnings call

Oct 16, 2026 Est · unconfirmed · in 5 wks

Latest filing: 10-K

filed Jul 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$95.13M

Trailing 12 months

Net income (TTM)

−$131.61M

Trailing 12 months

Revenue growth YoY

+66.2%

Year over year

Operating margin

-141.6%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

-8.4%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$153.78M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+180.9%

Year over year · more shares

Price change (1Y)

+29.6%

Trailing year

Short interest

5.1%

Latest settlement · 12.4 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Weak Sentiment Bullish Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 15.8 · calm Equity put/call 0.58

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −3%

below

Price vs 50-day avg −10%

below

RSI (14) 33

neutral

MACD trend Negative

52-week position 48%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Weak

1-month return −18%

trailing

6-month return +20%

trailing

YTD return −14%

this year

Relative strength +2%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $25 › 200d $24 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +15 funds added

Insider flow Distributing

Net -$4.5M over 90 days · 100% sells

Short interest Falling

5.07% of float · ▼ -1.5% MoM · 12.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

108 holders — near 1-yr high, broad support

Squeeze score 61

elevated · 0–100

Fundamentals

Strong

Revenue growth +59%

Y/Y

Gross margin 51%

expanding

EPS growth +53%

Y/Y

Free cash flow $-116.6M

Quant / Vol

risk profile

Very High

Volatility 65%

annualized · 1-yr

Max drawdown −36%

past year

ATR 5.8%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Jul 14, 2026

Revenue · FY27 Initiated $137M

prior FY $95.13M midpoint +44.0% Y/Y

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

2 · 5 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−3% Neutral

Price vs 50-day avg

−10% Bearish

RSI (14)

33 Neutral

MACD trend

Negative Bearish

52-week position

48% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $25 › 200d $24 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +15 funds added

Insider flow Distributing

Net -$4.5M over 90 days · 100% sells

Short interest Falling

5.07% of float · ▼ -1.5% MoM · 12.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

108 holders — near 1-yr high, broad support

Price context

position in its 52-week range

Range low $18 Now $23 · 48% Range high $28

vs 200-day avg -3% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Instruments & Supplies — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
KMTS Kestra Medical Technologies, Ltd. this stock	$1.34B	-13.8%	+59.0%	—	5.1%
ISRG Intuitive Surgical Inc	$130.41B	-34.8%	+20.5%	42.4	2.2%
BDX Becton Dickinson & Co	$48.44B	—	+8.2%	—	3.9%
MDLN Medline Inc.	$42.77B	-22.5%	+11.5%	—	3.0%
ALC Alcon Inc	$31.92B	-16.2%	+10.5%	—	3.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

108

% held: 100.2%
Net QoQ: +294.3K sh
Top holder: Bain Capital Investors LLC

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

3.0M

Days to cover: 12.4d
Change: -44.3K sh

View

Short Volume

Short vol %

64%

As of: Sep 11, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $84
As of: Aug 12, 2026

View

Off-Exchange

Off-exchange %

37.5%

Week of: Aug 3, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$4.5M

Buyers / Sellers: 0 / 9

Buyers Sellers

View

Financials

Revenue (FY)

$95.1M

Net income (FY): $-131.6M
EPS diluted: $-2.43

View

Filings

SEC Filings

Latest

8-K

Filed: Sep 10, 2026
This year: 6

View

Proposed Sales

Value

$97.9K

Shares: 3.9K
Filed: Sep 8, 2026

View

Earnings & Events

Earnings Calls

Last call

Jul 14, 2026

View

Investor Relations

Upcoming events

View

Performance

	5D	20D	120D	MTD	YTD
KMTS	-9.1%	-17.6%	+19.6%	-11.3%	-13.8%
SPY	-1.2%	-1.8%	+17.8%	-0.4%	+12.1%
vs SPY	-8.0%	-15.9%	+1.8%	-10.9%	-25.9%

Key facts CIK 1877184 CUSIP G52441105 13F (30d) 43 filings 43 filers Visit website Investor relations

KMTS · Kestra Medical Technologies, Ltd.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance